Symbol="TRVN"
AssetType="Common Stock"
Name="Trevena Inc"
Description="Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania."
CIK="1429560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="11998100"
EBITDA="-41079000"
PERatio="None"
PEGRatio="0"
BookValue="0.713"
DividendPerShare="0"
DividendYield="0"
EPS="-4.29"
RevenuePerShareTTM="0.286"
ProfitMargin="0"
OperatingMarginTTM="-16.0"
ReturnOnAssetsTTM="-0.499"
ReturnOnEquityTTM="-1.668"
RevenueTTM="2589000"
GrossProfitTTM="-3436000"
DilutedEPSTTM="-4.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="5.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="106.03"
PriceToBookRatio="0.569"
EVToRevenue="18.8"
EVToEBITDA="0.132"
Beta="1.914"
num_52WeekHigh="5.58"
num_52WeekLow="0.58"
num_50DayMovingAverage="0.923"
num_200DayMovingAverage="1.34"
SharesOutstanding="13712100"
DividendDate="None"
ExDividendDate="None"
symbol="TRVN"
open="0.87"
high="0.89"
low="0.86"
price="0.88"
volume="29746.00"
latest_trading_day="2023-08-30"
previous_close="0.88"
change="0.00"
change_percent="0.4571%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="1834335"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="506"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0099.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
